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Abstract
Objective—Evaluate the relationship between school climate and ADHD medication treatment 
among adolescents in Medicaid in Georgia (GA).
Methods—School climate and Medicaid claims data were aggregated for 159 GA counties. 
County-level school climate percentile and medicated ADHD prevalence were calculated. T-tests 
and regression evaluated the relationship between school climate, medicated ADHD, and 
demographics, weighted by county population. Poorer 2008 school climate (<25th percentile) was 
regressed on 2011 medicated ADHD prevalence, controlling for potential confounders.
Results—The prevalence of medicated ADHD was 7.8% among Medicaid-enrolled GA 
adolescents. The average county-level prevalence of medicated ADHD was 10.0% (SD=2.9%). 
Poorer school climate was associated with lower rates of medicated ADHD (p<0.0001) and with 
demographics accounted for 50% of the county variation in medicated ADHD.
Conclusions—School climate is associated with medicated ADHD among adolescents in 
Medicaid. Additional research may reveal whether high medicated ADHD may reflect a lack of 
access to non-pharmacological therapies.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a chronic, neurodevelopmental disorder 
with childhood onset that impacts the regulation of attention, activity-level, and impulses 
(American Psychiatric Association, 2013). Approximately 11% of U.S. children (aged 4–17 
years) have been diagnosed with ADHD by a health care provider as reported by parents 
(Susanna N. Visser et al., 2014), making ADHD the most prevalent mental disorder of 
childhood (Perou et al., 2013). The prevalence of diagnosed ADHD has increased by 3–6% 
per year since 1997 (Akinbami, Liu, Pastor, & Reuben, 2011; Susanna N. Visser et al., 
2014). The estimated annual societal costs of childhood ADHD are massive and span 
multiple sectors, totaling $38–$72 billion (Doshi et al., 2012). The negative consequences of 
childhood ADHD include higher rates of unintentional injury, emergency room visits, peer 
problems, and academic failure (DiScala, Lescohier, Barthel, & Li, 1998; Hoare & Beattie, 
2003; Loe & Feldman, 2007; Merrill, Lyon, Baker, & Gren, 2009). ADHD persists into 
adulthood for at least one-third of children and is associated with employment challenges, 
incarceration, co-occurring mental disorders, divorce, suicide, and significant family 
disturbance (Barbaresi et al., 2013; de Graaf et al., 2008; Harpin, 2005).
Clinical guidelines exist for the diagnosis and treatment of ADHD (American Academy of 
Child and Adolescent Psychiatry, 2007; American Academy of Pediatrics, 2011). Current 
treatment guidelines recommend that adolescents with ADHD be treated with an ADHD 
medication alongside behavioral therapy, if possible (American Academy of Pediatrics, 
2011). ADHD treatment is very effective for managing ADHD symptoms and impairment, 
with effect sizes (proportion of a standard deviation) ranging from .6 for behavioral 
strategies and .7 for non-stimulant medications to 1.0 for stimulant medications (American 
Academy of Pediatrics, 2011).
Parents report that 11.4% of youth in middle-school and 10.2% of youth in high-school had 
current ADHD in 2011–12; 8.0% of middle-schoolers and 6.4% of high schoolers were 
taking medication for ADHD, a significant increase of approximately 25% since 2007–08 
(Susanna N. Visser et al., 2014). These increases reflect the substantial (80%) increases in 
ADHD medication prescriptions for methylphenidate and amphetamine products among 
preteens and teens from 1998–2005 (Setlik, Bond, & Ho, 2009). Increasing academic 
demands and perceived school pressures are cited as factors in the increasing trends in 
adolescent ADHD (Graf et al., 2013), as is increased awareness of ADHD and its treatment 
among primary care practitioners (Wolraich, Bard, Stein, Rushton, & O’Connor, 2010). 
However, factors influencing these trends are not fully understood.
Previous research suggests that ADHD and medicated ADHD rates are associated with 
demographic factors, including being male, non-Hispanic, speaking English as a primary 
language, living in poverty and having insurance (Susanna N. Visser et al., 2014). There is 
also substantial state-based variability in rates of medicated ADHD, from 2% in Nevada to 
10% in Kentucky and Louisiana (Susanna N. Visser et al., 2014). State variation in 
prevalence has been partially explained by state demographics (race and public insurance 
coverage) and the characteristics of the state’s physicians; higher state proportions of 
younger physicians (<45 years) are associated with higher state-based rates of diagnosed and 
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medicated ADHD (Fulton et al., 2009). Ecological analyses suggest that school policies, 
practices, and accountability laws may contribute to state-based variation in ADHD rates. 
Specifically, consequential accountability laws and high school exit exams predict higher 
ADHD rates (Hinshaw & Scheffler, 2014). Thus, in addition to demographic characteristics 
of children and their health care practitioners, school policies and practices may contribute 
to ADHD and medicated ADHD rates. Among these, school policies and practices have 
received the least attention, despite the tremendous influence that schools have on child 
development, including the development of their attitudes, motivation, behaviors, cognitive 
abilities, and social competence (Sylva, 1994).
School climate reflects quality and character of school life and incorporates four key areas: 
safety, interpersonal relationships, teaching and learning, and institutional environment 
(Cohen & Geier, 2010; National School Climate Council, 2007). Poorer student-perceived 
school climate is associated with individual and community characteristics (Kuperminc, 
Leadbeater, Emmons, & Blatt, 1997; Way, Reddy, & Rhodes, 2007) as well as negative 
indicators of academic, socio-emotional, and behavioral health (Thapa, Cohen, Guffey, & 
Higgins-D’Alessandro, 2013), including higher rates of truancy (Sommer, 1985), lower 
global and academic self-esteem (Hoge & et al., 1990; Way et al., 2007), higher rates of self-
reported and teacher-reported internalizing and externalizing problems among students, and 
more discipline referrals (Kuperminc et al., 1997; Way et al., 2007). There is a lack of 
research evaluating the association between student-perceived school climate and the 
presence of mental and behavioral disorders such as ADHD and associated health care 
utilization.
Identifying modifiable factors that may influence health-care utilization patterns of children 
and adolescents with ADHD may have important implications for school-based policy, 
practice, and health promotion of those with ADHD. Research at the school district and 
county levels may be most useful, as school policies and practices are often implemented at 
these levels. Focusing on factors associated with health care utilization among adolescents 
with ADHD has potential to identify opportunities to positively impact those most likely to 
have ADHD persisting into adulthood (i.e., symptomatic adolescents).
Earlier work has shown that estimates of medicated ADHD from a parent survey were 
similar to rates of medicated ADHD among children from data drawn from insurance data 
(S. N. Visser, Danielson, Bitsko, Perou, & Blumberg, 2013). These findings suggest the use 
of claims data on ADHD medication treatment as a reasonable proxy for identifying 
prevalence of medicated ADHD in state-based analyses of ADHD.
This study intends to evaluate the association between student-perceived school climate and 
medicated ADHD prevalence among low-income adolescents, using county-level school 
climate and Medicaid claims data from the state of Georgia (GA), which has an average 
state-based prevalence of current ADHD of 9.3%, ranked 25th in the nation (Centers for 
Disease Control and Prevention, 2014). Given previous research indicating a relationship 
between poorer school climate and poor socio-emotional and behavioral health, we expect 
that poorer school climate will be associated with higher ADHD prevalence and reflect 
higher rates of medicated ADHD.
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Methods
This cross-system analysis utilizes school climate data from the GA Department of 
Education and Medicaid claims data from the GA Department of Community Health to 
explore the relationship between county-aggregated student ratings of school climate and 
ADHD medication treatment among adolescents enrolled in the GA Medicaid program. 
Data are aggregated to the county level at the respective Department to ensure patient and 
student privacy and reduce disclosure risks. The study methods were reviewed by the 
Human Subjects Protection offices of the University of Illinois at Chicago and the Centers 
for Disease Control and Prevention.
Data
School Climate—Student-perceived school climate is the primary independent variable. 
Since 2008, the GA Department of Education has conducted school climate assessments of 
middle and high school students through an anonymous annual web-based survey (Georgia 
Student Health Survey II: GSHS II), including questions on alcohol and drug use, nutrition 
and dietary behaviors, thoughts of suicide and self-harm, bullying, unsupervised time, and 
well-being. The survey also includes nine school climate questions that track to four school 
climate focus areas; safety, teaching and learning, inter-personal relationships, institutional 
environment, (Appendix) which sum to an overall school climate score (Cohen & Geier, 
2010).
School climate scores were averaged across students for state and county to create state and 
county-averaged school climate indicators. The county-level school climate scores were 
standardized (z-score transformation), converted to percentiles based on the state-level score, 
and dichotomized for analysis (bottom versus top three quartiles). The 2008 and 2011 
GSHS-II data were used in this analysis, with 2008 data used to create the primary 
independent variable to ensure that the school climate preceded in time the 2011 ADHD 
outcomes, regardless of age, thereby strengthening our ability to make causal assertions. To 
assess the potential impact that concurrent school climate had on 2011 medicated ADHD 
prevalence, a difference score was calculated between the 2011 and 2008 county-level 
school climate percentiles; this score was converted to a dichotomous indicator to indicate 
stability or improvement versus a decline in school climate from 2008–2011.
Medicated ADHD Prevalence—GA Medicaid data from 2011 were used to create a 
medicated ADHD indicator, the primary dependent variable. The indicator reflected the 
percentage of adolescents (aged 11–17 years) enrolled in Medicaid as of January 2011 with 
at least one ADHD ICD diagnosis code (314.×) and at least one claim for a medication 
approved by the Food and Drug Administration for pediatric ADHD treatment (Table 1), 
based on National Drug Codes. This indicator was aggregated at county-level based on child 
addresses and merged with county-level school climate data to facilitate analysis, with 
counts of five or less suppressed to reduce disclosure risks.
In order to confirm that the Medicaid ADHD medication indicator was a good proxy for 
medicated ADHD prevalence, state-based weighted estimates of medication treatment for 
ADHD were calculated for GA adolescents (aged 11–17 years) with Medicaid health 
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insurance, using data from the 2011–12 National Survey of Children’s Health (NSCH) 
(Centers for Disease Control and Prevention, 2013). The NSCH is a national cross-sectional, 
random-digit–dialed telephone survey of parents that collects information about health and 
well-being of non-institutionalized US children. Detailed information about the ADHD-
related survey content has been summarized previously (Susanna N. Visser et al., 2014). The 
survey data were analyzed using SUDAAN 11.0 to account for NSCH’s complex design. 
The ADHD prevalence estimate with its associated confidence interval was then compared 
to the state-based indicator for medicated ADHD among adolescents (aged 11–17 years) in 
Medicaid.
County-Level Demographic Indicators—The following county-level factors were 
collected from the 2012–2013 Area Health Resource Files (ahrf.hrsa.gov) and used as 
control factors in the analyses: 2011 county population, county urbanicity (metro, non-
metro), black race proportion, proportion of children living below the poverty threshold, the 
ratio of pediatricians to children, and the presence of a Federally Qualified Health Center 
(FQHC) in the county. An index of each county’s overall health outcomes was also included 
as a covariate (Robert Wood Johnson, 2014). The county factors related to child race and 
poverty were dichotomized (median split) to facilitate analysis and interpretation. County 
population was dichotomized using the top two deciles as an indicator of a large county 
population.
Statistical Approach
There are 159 Georgia counties; 150 had valid 2011 ADHD claims and 2008 school climate 
survey data. In the absence of a clear claims data algorithm for ADHD prevalence, this 
analysis focused on medicated prevalence, which was operationalized by having at least one 
ADHD diagnosis code and at least one ADHD medication claim in 2011. ArcGIS 10.0 was 
used to depict GA county-level school climate percentiles and the percentages of medicated 
ADHD among adolescents in Medicaid. Because the school climate indicators were based 
on individual-level ratings and county size varies dramatically across GA counties, all 
analyses evaluating the relationship between school climate, medicated ADHD prevalence, 
and the control variables were weighted by county population.
Weighted t-tests were used to evaluate the relationship between the independent and 
dependent variable and each of the potential confounding variables of county urbanicity, 
large population size, black race proportion, proportion of children below the 2010 poverty 
threshold, and county presence of a FQHC. Bivariate weighted linear regression was used to 
evaluate the relationship between the independent and dependent variable and the 
continuous variables of pediatrician to child ratio and the county health outcome index.
Weighted linear regression models estimated 2011 ADHD medication treatment from 2008 
school climate, while adjusting for county-level demographics that were significantly 
associated with either 2011 medicated ADHD prevalence or 2008 school climate. To 
determine if school climate had a similar impact on medicated ADHD prevalence in counties 
with higher and lower proportions of children in poverty, which relates to the 
generalizability of this Medicaid-based analysis, an interaction term was tested for 
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proportion of poverty and school climate. The model also included the school climate 
change indicator and the interaction term for school climate and poverty. To ensure model 
parsimony, the independent factors were manually trimmed in a backward stepwise manner, 
removing the demographic factor with the highest p-value from the model, one at a time, 
until removal of remaining factors reduced the model variation explained (R2) by 10% or 
more.
Results
County Demographics
The 150 counties varied in population size from 1,717 to 920,581, with an average county 
size of 63,845 (standard deviation (SD)=130,284; median=23,577). On average, the counties 
were 25.7% black race (SD=16.6%; median=25.1%) and 70.3% white race (SD=16.5%; 
median=70.5%). The county average for the percentage of children living under the 2010 
poverty threshold was 30.9% (SD=9.3%; median=31.6%).
School Climate
Of the 150 counties, 33 (22%) fell below the 25th percentile for state-wide 2008 school 
climate and were categorized as having poorer school climate (Figure 1). County-level 
school climate ratings for 2008 and 2011 were significantly and positively correlated 
(r=0.245; p=0.0038). Of the 138 counties with school climate data for both 2008 and 2011, 
43.5% had declining school climate percentiles and the remaining 56.5% had stable or 
increasing school climate percentiles.
Bivariate analyses revealed that better county-level school climate ratings were associated 
with the following county characteristics: non-metro, smaller population size, and higher 
rates of poverty (Table 2). A lower ratio of pediatricians to children was significantly 
associated with higher school climate percentiles (F(1,148)=11.27, p=0.001), as was better 
overall county health (F(1,146)=33.58, p<0.0001).
ADHD Medication Treatment
In 2011, 30,951 Medicaid-enrolled adolescents had at least one ADHD diagnosis code and 
at least one ADHD medication code (7.8% of adolescents in Medicaid). The prevalence of 
ADHD medication treatment from Medicaid claims data was similar to, but slightly lower 
than, the 2011–12 NSCH estimate of the percentage of GA adolescents in Medicaid taking 
medication for ADHD treatment (8.4%, 95% confidence interval: 4.4%–15.6%), suggesting 
convergence of the two indicators ADHD medication treatment estimates for adolescents in 
Medicaid. The average percentage of adolescents in Medicaid with at least one ADHD 
diagnosis code and one ADHD medication code in each county was 10.0% (range: 3.9%–
17.1%; SD=2.9%; Figure 2).
Significant bivariate associations were identified for all seven potential confounding 
variables and percentage of medicated ADHD. Specifically, associations were found for 
higher county-level percentages of medicated ADHD and counties that were non-metro, less 
populous, did not have a FQHC in the county, had lower black race proportions, and had 
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higher proportions of children in poverty (Table 2). A higher pediatrician to child ratio was 
significantly associated with lower medicated ADHD percentages (F(1,148)=33.38, 
p<0.0001). Better overall county health was also associated with higher percentages of 
medicated ADHD (F(1,145)=43.26, p<0.0001).
Poorer school climate (below 25th percentile) was significantly associated with lower 
county-level medicated ADHD percentages. Specifically, the county-level percentage of 
medicated ADHD among adolescents in Medicaid was 29.9% lower in poorer school 
climate counties (6.1%) than in counties with better school climate (8.7%; p<0.0001; Table 
3).
Multivariate Regression Models
Based on the weighted regression model, poorer 2008 school climate, large population size, 
higher proportions of black race, and lower county health outcome score were significantly 
associated with lower 2011 county-level medicated ADHD prevalence for adolescents in 
Medicaid (Table 3; F(1,130)=32.37, p<0.0001); these factors collectively accounted for 50% 
of the county variation in medicated ADHD. The multivariate results suggest that the highest 
percentages of medicated ADHD were among counties with better school climate ratings, 
smaller county population, a lower proportion of black race, and better county health. 
Conversely, the counties with the lowest medicated ADHD percentages had poorer school 
climate ratings, larger county population, a higher proportion of black race, and poorer 
county health.
Discussion
Contrary to expectations, in this county-level analysis, low student-perceived school climate 
was associated with lower rates of later medicated ADHD prevalence among GA 
adolescents enrolled in Medicaid, independently accounting for 20% of the variation in this 
county-level health care utilization outcome. The percentage of Medicaid-enrolled 
adolescents who received ADHD medication treatment was 29.9% lower in counties with 
poorer school climate, compared to those with better school climate. After controlling for 
potential confounders, poorer school climate remained significantly associated with lower 
ADHD medication rates, independently accounting for a decrease of approximately one 
percentage point in the county-level percentage of medicated ADHD among adolescents in 
Medicaid.
In the multivariate analysis, the demographic factors associated with low county-level 
medicated ADHD prevalence included large county population size, high proportion of 
black race, and poor overall county health. This was unexpected because adolescents with 
greater demographic risk would be expected to have more behavioral health problems, 
including ADHD, resulting in a greater need for ADHD medication treatment. Because 
medicated ADHD is a complex outcome, partially reflecting prevalence of the disorder and 
partially reflecting health care availability and access, considering each significant factor 
individually may serve to explain this complex set of findings.
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Urban, more populous counties are typically more likely to receive preventative health care 
services, due to improved access to health care services and facilities (Casey, Thiede Call, & 
Klingner, 2001). In this analysis, more populous county size was the strongest predictor of 
lower medicated ADHD prevalence, independently accounting for a 2.8% lower rate of 
medicated ADHD. Having a FQHC in the county was associated with lower county-level 
medicated ADHD prevalence in bivariate analyses, although it was not a significant factor in 
the model alongside population size. One way of explaining this is that adolescents in larger, 
urban areas may have increased access to behavioral therapy by having greater access to 
specialists who provide these therapies (e.g., psychologists), potentially resulting in less 
reliance on pharmacological treatments.
After county population size, poorer school climate and high proportion of black race each 
accounted for slightly more than a one percentage point decrease in the county-level 
percentage of medicated ADHD. Previous research has documented that black children are 
just as likely to have and be diagnosed with ADHD, but are less likely to receive ADHD 
medication treatment (Morgan, Staff, Hillemeier, Farkas, & Maczuga, 2013; Susanna N. 
Visser et al., 2014). Our county-level results are consistent with these findings. Lower rates 
of medicated ADHD among black children may result from cultural differences in the 
perception of ADHD diagnosis and medication treatment (Bussing, Schoenberg, & Perwien, 
1998; Yeh, Hough, McCabe, Lau, & Garland, 2004) or health care utilization barriers.
Better overall county health was significantly associated with higher ADHD medication 
rates. Although one might expect counties with higher county health ratings to have better 
adolescent behavioral health, healthier counties may also be more likely to have greater 
health care utilization overall, resulting in higher county-level ADHD medication rates. 
Future research that incorporates a direct assessment of behavioral health taking into account 
school climate, ADHD-related health care utilization, and demographics could disentangle 
these contextual factors.
Given the extensive research documenting association between better school climate and 
fewer student- and teacher-reported internalizing and externalizing problems (Kuperminc, 
Leadbeater, & Blatt, 2001; Kuperminc et al., 1997), it was surprising that better school 
climate was not associated with less ADHD medication treatment. The similarity between 
the GA NSCH parent survey estimate and GA Medicaid rate suggests that the Medicaid 
claims indicator is a valid indicator of medicated ADHD among adolescents in Medicaid 
and reduces the likelihood that this finding is spurious. One explanation for this finding is 
that poorer school climate may be associated with factors that negatively influence health 
care utilization patterns, resulting in unexpectedly low rates of medicated ADHD. For 
example, schools with poorer school climate could be less attentive to student behavioral 
needs, resulting in lower rates of student referrals for behavioral assessment and lower 
subsequent rates of ADHD-related health care utilization. Indeed, improving school climate 
is recommended as a strategy to increase school connectedness (Centers for Disease Control 
and Prevention, 2009) and the GA school climate survey specifically asks about the 
availability of a counselor that would help a needy student. Therefore, better school climate 
could reflect greater connectedness between students and school staff and, potentially, 
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greater connection to behavioral resources that include ADHD-related health care 
utilization.
It is also important to recognize that higher rates of ADHD medication treatment do not 
necessarily constitute a better outcome. Although it is important that children with ADHD 
receive evidence-based ADHD treatments to improve their functional, developmental, and 
health outcomes (American Academy of Pediatrics, 2011), there is also concern about risk 
of over-medication, particularly in light of rapidly increasing rates of medicated ADHD 
(Setlik et al., 2009; Susanna N. Visser et al., 2014). It may be appropriate to be concerned 
both about counties with the lowest (4%, approximately half the state-average) and highest 
(17%, more than twice the state-average) rates of medicated ADHD. While school climate 
may be an important correlate of ADHD medication treatment, it is important to consider 
other factors that relate to higher rates of medicated ADHD, particularly among smaller, 
predominantly white GA counties.
There are several important limitations to this county-level analysis. First, this study focused 
on Georgia adolescents in Medicaid and the results are not necessarily generalizable to other 
states, children with other insurance, or children in poverty who are eligible but not enrolled 
in Medicaid. Second, 21 Georgia city school districts were allocated to counties for analysis, 
making it impossible to determine if there were unique patterns among city districts. Third, 
school climate data were collected from public school students and do not represent the 
7.5% of Georgia students in private schools. Finally, and importantly, the school climate 
surveys were anonymous and could not be linked to claims data at the individual-level. 
Therefore, this study is subject to the limitations of ecological analyses in that without 
individually-linked data, findings can suggest but not determine relationships between the 
county-level factors. Further, the analysis is relatively crude in that it does not account for 
the intra-county variation of school climate ratings.
Despite these limitations, this study is the first of its kind to use school climate data and 
behavioral health claims data to help us better understand the relationship between school 
climate and medicated ADHD, an indicator of socio-emotional and behavioral health. 
Results of this analysis suggest that school climate improvement is associated with more 
health care utilization and ADHD medication treatment in particular, among adolescents in 
Medicaid. This finding adds to the body of knowledge that suggests that school-related 
factors may play a role in medicated ADHD prevalence (Connor, 2011; Hinshaw & 
Scheffler, 2014; McDonald & Jalbert, 2013). School climate is modifiable and typically 
asset-based. Therefore, if ADHD is undertreated in some schools, then school climate 
improvement may benefit the outcomes of adolescents with ADHD in Medicaid, further 
supporting efforts to train school staff on multi-tiered school climate improvement programs 
(U.S. Department of Education, 2014). However, additional research is needed to better 
understand factors related to high county-level medicated ADHD rates and if these counties 
lack access to other evidence-based ADHD treatments, such as behavioral therapy.
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Implications and Contribution
This county-level analysis is the first to evaluate ADHD-related health care utilization as 
a function of school climate. The results suggest that poorer school climate is associated 
with lower ADHD medication rates among adolescents in Medicaid. Better school 
climate is related to and may promote ADHD-related health care utilization, specifically 
ADHD medication treatment.
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Figure 1. 
School climate percentile* by county in Georgia: Georgia Student Health Survey II, 2008
*School climate was assessed using the Georgia Student Health Survey II (Appendix), 
which assesses the quality and character of school life across four key areas (safety, 
interpersonal relationships, teaching and learning, and institutional environment).
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Figure 2. 
Prevalence of medicated Attention-Deficit/Hyperactivity Disorder* among adolescents 
(aged 11–17 years) in Medicaid: Georgia, 2011
*Attention-Deficit/Hyperactivity Disorder prevalence was assessed from 2011 Georgia 
Medicaid claims data, requiring at least one ADHD ICD-9 code (314.×) and at least one 
claim for an FDA-approved ADHD medication (see Table 1 for a list of medications).
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Table 1
List of FDA-approved ADHD medications* used in the abstraction of medication claims for Attention-Deficit/
Hyperactivity Disorder among adolescents in Medicaid
Medication Drug Class
Adderall Central nervous system stimulant (CNS Stimulant)
Atomoxetine Selective norepinephrine reuptake inhibitor (SNRI)
Concerta CNS Stimulant
Daytrana Patch CNS Stimulant
Dexedrine CNS Stimulant
Dextrostat CNS Stimulant
Dextro-Amphetamine CNS Stimulant
Dexmethylphenidate CNS Stimulant
Focalin CNS Stimulant
Guanfacine Centrally acting alpha-adrenergic receptor agonist
Intuniv Centrally acting alpha-adrenergic receptor agonist
Kapvay Central alpha-2 agonist
Metadate CNS Stimulant
Methylin CNS Stimulant
Methylphidate CNS Stimulant
Ritalin CNS Stimulant
Strattera SNRI
Tenex Centrally acting alpha-adrenergic receptor agonist
Vyvanse CNS Stimulant
*As of 2011
J Atten Disord. Author manuscript; available in PMC 2020 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Visser et al. Page 17
Ta
bl
e 
2
Co
un
ty
*
 
po
pu
la
tio
n-
w
ei
gh
te
d 
bi
v
ar
ia
te
 re
la
tio
ns
hi
ps
 b
et
w
ee
n 
co
un
ty
 d
em
og
ra
ph
ic
 fa
ct
or
s,
 s
ch
oo
l c
lim
at
e 
pe
rc
en
til
e,
 a
nd
 th
e 
pr
ev
al
en
ce
 o
f m
ed
ic
at
ed
 
A
tte
nt
io
n-
D
ef
ic
it/
H
yp
er
ac
tiv
ity
 D
iso
rd
er
 (A
DH
D)
 am
on
g G
eo
rgi
a 
ad
ol
es
ce
nt
s i
n 
M
ed
ic
ai
d
C
ou
nt
y 
D
em
og
ra
ph
ic
 F
a
ct
or
M
ea
n 
W
ei
gh
te
d 
Pe
rc
en
til
e 
C
ou
nt
y 
Sc
ho
ol
 C
lim
at
e
t
p-
v
a
lu
e
M
ea
n 
W
ei
gh
te
d 
%
 o
f M
ed
ic
at
ed
 A
D
H
D
ˆ
t
p-
v
a
lu
e
%
 B
la
ck
+
 
H
ig
he
r (
>2
5%
)
33
.9
%
7.
0%
 
Lo
w
er
 (<
=2
5%
)
38
.2
%
1.
23
0.
22
09
8.
6%
3.
39
0.
00
09
U
rb
an
ic
ity
 
M
et
ro
31
.3
%
7.
0%
 
N
on
-M
et
ro
55
.1
%
5.
90
<
0.
00
01
10
.5
%
5.
87
<
0.
00
01
%
 P
ov
er
ty
+
 
H
ig
he
r (
>3
2%
)
49
.1
%
9.
4%
 
Lo
w
er
 (<
=3
2%
)
29
.8
%
−
5.
59
<
0.
00
01
6.
9%
−
4.
80
<
0.
00
01
FQ
HC
Ϯ  i
n 
Co
un
ty
 
N
o
39
.5
%
9.
1%
 
Ye
s
33
.3
%
1.
72
0.
08
69
6.
8%
4.
73
<
0.
00
01
Po
pu
la
tio
n 
Si
ze
*
*
 
Sm
al
le
r (
<=
89
,89
0)
50
.5
%
10
.5
%
 
La
rg
er
 (8
9,8
91
–9
20
,58
1)
26
.7
%
7.
16
<
0.
00
01
6.
1%
10
.1
8
<
0.
00
01
*
B
as
ed
 o
n 
da
ta
 fr
om
 1
50
 o
f 1
59
 co
un
tie
s i
n 
G
eo
rg
ia
 w
ith
 v
al
id
 d
at
a 
on
 sc
ho
ol
 c
lim
at
e,
 th
e 
de
m
og
ra
ph
ic
 fa
ct
or
s,
 a
nd
 m
ed
ic
at
ed
 A
D
H
D
.
ˆ
Th
e 
pr
ev
al
en
ce
 o
f m
ed
ic
at
ed
 A
D
H
D
 re
fle
ct
s t
he
 p
er
ce
nt
ag
e 
of
 a
do
le
sc
en
ts 
in
 M
ed
ic
ai
d 
w
ith
 a
t l
ea
st 
on
e 
A
D
H
D
 d
ia
gn
os
is 
co
de
 a
nd
 a
t l
ea
st 
on
e 
A
D
H
D
 m
ed
ic
at
io
n 
cl
ai
m
 in
 2
01
1
+
G
ro
up
ed
 b
y 
m
ed
ia
n 
sp
lit
Ϯ F
QH
C 
= F
ed
era
lly
 Q
ua
lif
ie
d 
H
ea
lth
 C
en
te
r
*
*
G
ro
up
ed
 in
to
 to
p 
tw
o
 d
ec
ile
s a
nd
 b
ot
to
m
 8
 d
ec
ile
s
J Atten Disord. Author manuscript; available in PMC 2020 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Visser et al. Page 18
Ta
bl
e 
3
W
ei
gh
te
d 
re
gr
es
sio
n 
an
al
ys
es
 o
f t
he
 c
ou
nt
y-
le
v
el
* 
pr
ev
al
en
ce
 o
f m
ed
ic
at
ed
 A
tte
nt
io
n-
D
ef
ic
it/
H
yp
er
ac
tiv
ity
 D
iso
rd
er
* 
(A
DH
D)
 am
on
g G
eo
rgi
a 
ad
ol
es
ce
nt
s i
n 
M
ed
ic
ai
d 
as
 a
 fu
nc
tio
n 
of
 2
00
8 
co
un
ty
-le
v
el
 sc
ho
ol
 c
lim
at
e
C
ru
de
 M
od
el
ˆ
A
dju
ste
d M
od
el+
Fa
ct
or
B
SE
 B
t
p
B
SE
 B
t
p
In
te
rc
ep
t
0.
08
7
0.
00
3
26
.3
6
<
0.
00
01
0.
11
2
0.
00
4
27
.9
0
<
0.
00
01
Po
or
er
 S
ch
oo
l C
lim
at
e 
(bo
tto
m 
qu
art
ile
)
−
0.
02
6
0.
00
5
−
5.
19
<
0.
00
01
−
0.
01
0
0.
00
4
−
2.
37
0.
01
9
La
rg
e 
Po
pu
la
tio
n 
Si
ze
 (>
=1
36
,15
2)
−
0.
02
8
0.
00
6
−
4.
66
<
0.
00
01
H
ig
he
r P
ro
po
rti
on
 B
la
ck
−
0.
01
2
0.
00
5
−
2.
61
0.
01
0
H
ea
lth
 O
ut
co
m
e 
z-
sc
or
e
0.
00
9
0.
00
4
2.
48
0.
01
43
*
Th
e 
pr
ev
al
en
ce
 o
f m
ed
ic
at
ed
 A
D
H
D
 re
fle
ct
s t
he
 p
er
ce
nt
ag
e 
of
 a
do
le
sc
en
ts 
in
 M
ed
ic
ai
d 
w
ith
 a
t l
ea
st 
on
e 
A
D
H
D
 d
ia
gn
os
is 
co
de
 a
nd
 a
t l
ea
st 
on
e 
A
D
H
D
 m
ed
ic
at
io
n 
cl
ai
m
 in
 2
01
1
ˆ
B
as
ed
 o
n 
th
e 
13
5 
co
un
tie
s w
ith
 v
al
id
 d
at
a 
on
 a
ll 
fa
ct
or
s 
in
 th
e 
ad
jus
ted
 m
od
el;
 R
2  
=
 0
.1
68
5;
 A
dj.
 R
2  
=
 0
.1
62
2;
 M
od
el
 F
 
=
 2
6.
36
, p
 
<
0.
00
01
+
B
as
ed
 o
n 
th
e 
13
5 
co
un
tie
s w
ith
 v
al
id
 d
at
a 
on
 a
ll 
fa
ct
or
s 
in
 th
e 
ad
jus
ted
 m
od
el;
 R
2  
=
 0
.4
99
0;
 A
dj.
 R
2  
=
 0
.4
83
6;
 M
od
el
 F
 
=
 3
2.
37
, p
 
<
0.
00
01
*
*
To
ta
l v
ar
ia
bl
es
 e
nt
er
ed
 in
to
 th
e 
fu
ll 
m
od
el
 b
ef
or
e 
ba
ck
w
ar
d 
ste
pw
ise
 p
ro
ce
du
re
s i
nc
lu
de
d 
di
ch
ot
om
ou
s i
nd
ic
at
or
s o
f 2
01
1 
co
un
ty
 p
op
ul
at
io
n,
 c
ou
nt
y 
ur
ba
ni
ci
ty
 (m
etr
o, 
no
n-m
etr
o),
 bl
ac
k r
ac
e p
rop
ort
ion
, 
pr
op
or
tio
n 
of
 c
hi
ld
re
n 
liv
in
g 
be
lo
w
 th
e 
po
v
er
ty
 th
re
sh
ol
d,
 th
e 
ra
tio
 o
f p
ed
ia
tri
ci
an
s t
o 
ch
ild
re
n,
 th
e 
pr
es
en
ce
 o
f a
 F
ed
er
al
ly
 Q
ua
lif
ie
d 
H
ea
lth
 C
en
te
r (
FQ
HC
) i
n t
he
 co
un
ty,
 
an
d 
an
 in
de
x
 o
f e
ac
h 
co
un
ty
’s
 
o
v
er
al
l h
ea
lth
 o
ut
co
m
es
.
J Atten Disord. Author manuscript; available in PMC 2020 February 01.
